Viridian Therapeutics

VRDNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.613 B

$23.06 -2.25%

Close of 10 Aug 2026

Revenue

—

Not reported

Earnings

-$342.6M

Loss-making

Shares outstanding

113,292,269

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#88Zai LabZLAB$2.65B
#89Ultragenyx PharmaceuticalRARE$2.64B
#90Viridian TherapeuticsVRDN$2.61B
#91Trevi TherapeuticsTRVI$2.54B
#92Nektar TherapeuticsNKTR$2.53B

Where these numbers come from

Share counts and financials for Viridian Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Aug 2026. Read the methodology.